Professor
Department of Medicine
University of Otago, Christchurch
PO Box 4345
Christchurch
New Zealand
Mark Richards is the director of the Christchurch Heart Institute.
He coordinates and directs multi-disciplinary programmes of grant-funded translational cardiovascular research which seek to improve diagnostic, prognostic and therapeutic options in heart disease.
He is pursuing studies of epidemiological, molecular biological, neurohormonal and therapeutic aspects of acute and chronic cardiovascular disorders including hypertension, coronary syndromes, and the full spectrum of heart failure.
Richards holds the Heart Foundation of New Zealand's Chair in Cardiovascular Studies.
He also holds joint appointments at the University of Otago and the National University of Singapore's Cardiovascular Research Institute.
Email mdcarthu@nus.edu.sg (University of Singapore)
Current roles
- Director, The Christchurch Heart Institute
- Consultant Cardiologist, The Canterbury District Health Board
Research interests
- Neurohormonal physiology and pathophysiology in cardiovascular health and disease
- Heart Failure
- Acute Coronary Syndromes
- Hypertension
- Vasoactive Hormones
- The Cardiac Natriuretic Peptides
Publications
Ong, C. W., Wee, I. J. Y., Toma, M., Cui, F., Xu, X. Y., Richards, A. M., … Choong, A. M. T. L. (2023). Haemodynamic changes in visceral hybrid repairs of type III and type V thoracoabdominal aortic aneurysms. Scientific Reports, 13, 13760. doi: 10.1038/s41598-023-40323-1
Journal - Research Article
Teramoto, K., Ouwerkerk, W., Tay, W. T., Tromp, J., Teng, T.-H. K., Chandramouli, C., … Richards, A. M., … on behalf of the ASIAN-HF investigators. (2023). Clinical features of heart failure with normal ejection fraction: Insights from the ASIAN-HF Registry. JACC: Asia. Advance online publication. doi: 10.1016/j.jacasi.2023.06.007
Journal - Research Article
Lee, V., Zheng, Q., Toh, D.-F., Pua, C.-J., Bryant, J. A., Lee, C.-H., … Richards, M., … Chin, C. (2023). Sacubitril/Valsartan versus Valsartan in regressing myocardial fibrosis in hypertension: A prospective, randomized, open-label, blinded endpoint clinical trial protocol. Frontiers in Cardiovascular Medicine. Advance online publication. doi: 10.3389/fcvm.2023.1248468
Journal - Research Other
Richards, A. M. (2023). Plasma markers to risk stratify for heart failure in atrial fibrillation [Invited]. European Journal of Heart Failure, 25, 842-844. doi: 10.1002/ejhf.2885
Journal - Research Other
Pua, C. J., Loo, G., Kui, M., Moy, W. L., Hii, A.-A., Lee, V., … Richards, A. M., … Chin, C. W. L. (2023). Impact of diabetes on myocardial fibrosis in patients with hypertension: The REMODEL study. Circulation: Cardiovascular Imaging, 16, e015051. doi: 10.1161/circimaging.123.015051
Journal - Research Article
Pemberton, C. J., Charles, C. J., & Richards, A. M. (2017). Cardiac natriuretic peptides. In J. C. Schisler, C. H. Lang & M. S. Willis (Eds.), Endocrinology of the heart in health and disease. (pp. 3-39). Elsevier. doi: 10.1016/B978-0-12-803111-7.00001-4
Chapter in Book - Research
Richards, M., & Rademaker, M. (2013). Urocortins. In A. Kastin (Ed.), Handbook of biologically active peptides. (2nd ed.) (pp. 1428-1436). San Diego, CA: Academic Press. doi: 10.1016/B978-0-12-385095-9.00194-9
Chapter in Book - Research
Richards, A. M., Troughton, R. W., & Nicholls, M. G. (2011). Natriuretic peptides for guidance of acute and chronic heart failure therapy. In J. L. Januzzi (Ed.), Cardiac biomarkers in clinical practice. (pp. 559-580). Sudbury, MA: Jones & Bartlett.
Chapter in Book - Research
Richards, A. M. (2009). What we may expect from biomarkers in heart failure. In E. Braunwald (Ed.), Biomarkers in heart failure: An issue of heart failure clinics (Vol.5-4). (pp. 463-470). Philadelphia, PA: Saunders. doi: 10.1016/j.hfc.2009.04.011
Chapter in Book - Research
Nicholls, M. G., & Richards, A. M. (2008). High-risk subgroups: Diabetes and hypertension. In A. Bayés-Genís & J. L. Januzzi (Eds.), NT-proBNP as a biomarker in cardiovascular diseses. (pp. 173-182). Thomson Reuters.
Chapter in Book - Research
Troughton, R. W., & Richards, A. M. (2008). Natriuretic peptides for disease monitoring in patients with chronic heart failure. In J. A. de Lemos (Ed.), Biomarkers in heart disease. (pp. 140-160). Malden, MA: Blackwell.
Chapter in Book - Research
Troughton, R. W., & Richards, A. M. (2008). Outpatient monitoring and treatment of chronic heart failure guided by NT-proBNP measurement. In A. Bayés-Genís & J. L. Januzzi (Eds.), NT-proBNP as a biomarker in cardiovascular diseases. (pp. 91-100). Thomson Reuters.
Chapter in Book - Research
Nicholls, M. G., & Richards, A. M. (2004). Looking at the adrenals as a primary source. In Handbook of Hypertension: Vol. 22. Hypertension in the Twentieth Century: Concepts and Achievements. (pp. 104-122). Amsterdam: Elsevier.
Chapter in Book - Research
Lainchbury, J. G., & Richards, A. M. (2003). Exercise testing in the assessment of chronic congestive heart failure. In P. Mills (Ed.), Education in heart, volume 3. (pp. 56-64). London: BMJ Books.
Chapter in Book - Research
Richards, M., & Nicholls, G. (2003). Endocrine causes of hypertension. In R. J. Johnson & J. Feehally (Eds.), Comprehensive clinical nephrology. (2nd ed.) (pp. 529-541). London, UK: Mosby.
Chapter in Book - Research
Nicholls, M. G., Richards, A. M., & Yandle, T. G. (2002). The renin-angiotensin system. In G. Mancia, J. Chalmers, S. Julius, T. Saruta, M. Weber, A. Ferrari & I. Wilkinson (Eds.), Manual of Hypertension. (pp. 77-95). London: Churchill Livingstone.
Chapter in Book - Research
Richards, A. M., Lainchbury, J. G., Nicholls, M. G., & Rademaker, M. T. (2000). Adrenomedullin in heart failure: Biochemical curiosity or pathophysiological player? In J. J. V. McMurray & J. G. F. Cleland (Eds.), Heart Failure in Clinical Practice. (2nd ed.) (pp. 105-125). London: Martin Dunitz.
Chapter in Book - Research
Nicholls, M. G., Richards, A. M., & Begg, E. J. (1999). Hypertension as a cause of heart failure: Is it still important? In J. J. V. McMurray & J. G. F. Cleland (Eds.), Heart Failure in Clinical Practice. (pp. 19-32). London: Martin Dunitz.
Chapter in Book - Research
Richards, A. M. (1999). Combined angiotensin convertin enzyme inhibition and angiotensin II type 1 receptor antagonism. In M. G. Nicholls, H. R. Brunner, H. Ikram, C. S. Sweet & J. F. Walker (Eds.), 100 Years of the Renin-Angiotensin System. (pp. 90-95). New Jersey, USA: Merck & Co..
Chapter in Book - Research
Richards, A. M., Nicholls, M. G., & Troughton, R. W. (1999). The pharmacotherapy of diuretics. In N. Sharpe (Ed.), Heart Failure Management 2000. (pp. 43-60). London: Martin Dunitz.
Chapter in Book - Research
Espiner, E. A., Richards, A. M., & Nicholls, M. G. (1998). Physiology of natriuretic peptides. In E. R. Levin & J. Nadler (Eds.), Endocrinology of Cardiovascular Function. Kluwer Academic Publishers.
Chapter in Book - Research
Nicholls, M. G., Richards, A. M., & Begg, E. J. (1998). Hypertension as a cause of heart failure - is it still important? In J. J. V. McMurray & J. G. F. Cleland (Eds.), Heart Failure in Clinical Practice (Second Edition). London: Dunitz.
Chapter in Book - Research
Lainchbury, J. G., Richards, A. M., & Nicholls, M. G. (1997). Brain natriuretic peptide in heart failure. In Atrial Natriuretic Peptides. (pp. 151-158).
Chapter in Book - Research
Nicholls, M. G., Richards, A. M., & Begg, E. J. (1997). Hypertension and heart failure. In A. Zanchetti & et al (Eds.), Hypertension and the heart. (pp. 273-279). New York: Plenum Press.
Chapter in Book - Research
Nicholls, M. G., Pidgeon, G. B., Lewis, L. K., & Richards, A. M. (1996). Ouabain, adrenal glands and hypertension. In G. P. Vinson & D. C. Anderson (Eds.), Adrenal Glands, Vascular System and Hypertension. (pp. 115-121). Bradley Stoke, Bristol, U.K.: Journal of Endocrinology Limited.
Chapter in Book - Research
Richards, M., Troughton, R., Espiner, E., Cameron, V., Ellmers, L., Pilbrow, A., Charles, C., Rademaker, M., Pemberton, C., & Yandle, T. (2013). Christchurch Heart Institute. In P. Joyce, G. Nicholls, K. Thomas & T. Wilkinson (Eds.), The Christchurch experience: 40 years of research and teaching. (pp. 68-74). Christchurch, New Zealand: University of Otago.
Chapter in Book - Other
Nicholls, M. G., & Richards, A. M. (2007). Endocrine causes of hypertension. In J. Feehally, J. Floege & R. J. Johnson (Eds.), Comprehensive clinical nephrology. (3rd ed.) (pp. 443-452). Philadelphia: Mosby.
Chapter in Book - Other
Nicholls, M. G., Richards, A. M., & Begg, E. J. (2000). Hypertension as a cause of heart failure: Is it still important? In J. J. V. McMurray & J. G. F. Cleland (Eds.), Heart failure in clinical practice. (2nd ed.) (pp. 19-31). United Kingdom: Martin Dunitz.
Chapter in Book - Other
Richards, A. M., Nicholls, M. G., & Troughton, R. W. (2000). Diuretic therapy: Essential in heart failure. In N. Sharpe (Ed.), Heart failure management. (pp. 43-59). United Kingdom: Martin Dunitz.
Chapter in Book - Other